Survival of children born with congenital heart defects in Costa Rica: a retrospective study of the birth cohort 2006-2007
DOI:
https://doi.org/10.51481/amc.v60i4.1016Keywords:
congenital heart defects, mortality, survival, epidemiologyAbstract
Background: Around the world, congenital heart defects occupy the first causes of infant mortality. In Costa Rica heart malformations are the most frequent group of birth defects, with a prevalence of 6 x 1000 births (95% CI 5-7 x 1000 births). They represent about 13% of infant mortality and are. the leading cause of death due to birth defects. The objective of this study is to analyze the survival of children with CC in Costa Rica.
Methods: A retrospective cohort of 543 children born with CC between January 2006 and June 2007 in Costa Rica was analyzed. Using medical records and the national database of deaths, a minimum follow-up of 5 years was given in all cases. Kaplan-Meier survival estimates were obtained at month, year and five years of life. Prognostic factors were assessed using the Cox proportional hazards model. Raw and adjusted relative risks were estimated with their respective 95% confidence interval.
Results: The prevalence of CC was 5.14 per 1000 births (95% CI: 4.73-5.60; n: 543) for the study period. Mortality was 27.9% (95% CI: 24.21-31.73; n: 152). Cumulative survival at one year and five years was 76.1% and 72.4%, respectively, compared to 99.1% and 98.8% of survival in the same national birth cohort (with and without CC), at the same age. Early age at diagnosis, severity, multiple CC and the association of major BD were significantly associated (p≤0.05) with a lower probability of survival.
Conclusions: The cohort of children with congenital heart disease studied had a high mortality rate at one year and five years. The worst prognosis of survival was for those who needed cardiac surgery at an early age.
Downloads
References
Van der Linde D, Konings E, Slager M et al. Birth Prevalence of Congenital Heart Disease Worldwide: a systematic review and meta-analysis. J Am Coll Cardiol. 2011;58(21):2241-7.
Bernier P-L, Stefanescu A, Samoukovic G and Tchervenkov C. The challenge of congenital heart disease worldwide: epidemiologic and demographic facts. Semin Thorac Cardiovasc Surg Pediatr Card Surg Ann. 2010;13:26-34.
Menackere Fand Martin JA. Expanded health data from the new birth certificate, 2005. Natl Vital Stat Rep. 2008;56(13):1-9.
Dolk H, Loane M, Garne E and a European Surveillance of Congenital Anomalies (EUROCAT) Working Group. Congenital Heart Defects in Europe: Prevalence and Perinatal Mortality, 2000 to 2005. Circulation. 2011;123:841849.
Khairy P, Ionescu-Ittu R, Mackie A, Abrahamowicz M, Pilote L and Marelli A. Changing mortality in congenital heart disease. J Am Coll Cardiol. 2010;56:1149-1157.
Khoshnood B, Lelong N, Houyel L et al. Prevalence, timing of diagnosis and mortality of newborns with congenital heart defects: a population-based study. Heart. 2012;98(22):1667-73.
Van der Bom T, Zomer A, Zwinderman A, Meijboom F, Bouma B and Mulder B. The changing epidemiology of congenital heart disease. Nat. Rev. Cardiol. 2011;8:50-60.
Zaidi AN, Daniels CJ. The adolescent and adult with congenital heart disease. In: Moss AJ, Adams FH. Eds. Moss and Adam´s heart disease in infants, children and adolescents; Eighth Edition. Wolters Kluwer/Lippincott Williams &Wilkins Philadelphia, 2013:1463-93.
Wren C and O´Sullivan JJ. Survival with congenital heart disease and need for follow up in adult life. Heart. 2001;85:468-433.
Sadowsky SL. Congenital cardiac disease in the newborn infant: past, present and future. Crit Care Nurs Clin N Am. 2009;21:37-48.
Yacoub M. Establishing pediatric cardiovascular services in the developing world: a wake-up call. Circulation. 2007;116:1876-78.
Instituto Nacional de Estadística y Censos. 2011-2025.Proyecciones nacionales. Indicadores demográficos proyectados por años calendario. http://www.inec. go.cr/poblacion/estimaciones-y-proyecciones-de-poblacion (Consultado 26 de Jul 2016).
Benavides-Lara A, Faerron Ángel JE, Umaña Solís L y Romero Zúñiga JJ. Epidemiología y registro de las cardiopatías congénitas en Costa Rica. Rev Panam Salud Pública. 2011;30(1):31-8.
Barboza-Argüello MP, Benavides-Lara A y Umaña Solís L. Mortalidad infantil por defectos congénitos en Costa Rica. Rev Panam Salud Pública. 2013;34(5)304-311.
Magliola R, Althabe M, Moreno G, Lenz A, Pilan MP, Landry L et al. Cirugía cardíaca reparadora en recién nacidos: experiencia de 5 años en cirugía neonatal con circulación extracorpórea. Arch Argent Pediatr. 2009;107(5): 417-422.
Savío A y Oliva J. Ecocardiografía fetal: evaluación de resultados de un programa nacional, Cuba 1989-1991. Rev Cubana Pediatr. 1995;67(1): 235-39.
Mendieta G, Santiago E, Mendieta H, Dorantes R, Ortiz G y Ortejo G. Incidencia de las cardiopatías congénitas y los factores asociados a la letalidad en niños en dos hospitales del Estado de México. Gaceta Médica de México. 2013;149:617-23.
Torres-Cosme JL, Rolón-Porras C, Aguinaga-Ríos M, Acosta-Granado PM, Reyes-Muñoz E, Murguía-Peniche T. Mortality from Congenital Heart Disease in Mexico: A Problem on the Rise. PLoS ONE.2016;11(3): e0150422. doi:10.1371/journal.pone.015042. Consultado 25 Set 2017.
Hu Z, Yuan X, Rao K, Zheng Z and Shengshou H. National trend in congenital heart disease mortality in China during 2003-2010: a population-based study. J Thorac Cardiovasc Surg. 2014;148:596-602.
Oster M, Lee KA, Honein M, Riehle-Colarusso T, Shin M and Correa A. Temporal trends in survival among infants with critical congenital heart defects. Pediatrics. 2013;131:1502-1508.
Cleves M, Ghaffar S, Zhao W, Mosley B and Hobbs C. First-year survival of Infants born with congenital heart defects in Arkansas (1993-1998): a survival analysis using registry data. Birth Defects Research (Part A): Clinical and Molecular Teratology. 2003;67:662-668.
Agha M, Williams J, MArrett L, To T and Dodds L. Determinants of survival in children with congenital heart abnormalities: a long-term population-based cohort study. Birth Defects Research (Part A). 2006;76:46-54.
Jortveit J, Oyen N, Leirgul E, Fomina T, Tell G, Vollset S, et al. Trend in Mortality of Congenital Heart Defects. Congenit Heart Dis. 2016;11:160-168.
Tennant P, Pearce M, Bythell M and Rankin J. 20- years survival of children born with congenital anomalies: a population-based study. Lancet. 2010; 375:649-56.
Pérez-Lescure J, Mosquera M, Latasa P y Crespo D. Mortalidad de las cardiopatías congénitas en España durante 10 años (2003-2012). An Pediatr. 2017.http://dx.doi.org//10.1016/j.anpedi.2017.06.002. Consultado 25 set 2017.
Landis BJ, Levey A, Levasseu SM, Glickstein JS, Kleinman CS, Simpson LL and Williams IA. Prenatal diagnosis of congenital heart disease and birth outcome. Pediatric Cardiol. 2013;34:597-605.
Brown KL, Ridout DA, Hoskote A,Verhulst L,Ricci M and Bull C. Delayed diagnosis of congenital heart disease worsens preoperative condition and outcome of surgery in neonates. Heart 2006;92:1298-1302.
Wright L, Ehrlichs A, Stauffer N, Samai C, Kogon B and Oster M. Relation of prenatal diagnosis with one-year survival rate for infant with congenital heart disease. Am J Cardiol 2014;113:1041-1044.
O´Donnell CP, Kamlin CO, Davis PG, Carlin JB, Morley CJ. Clinical assessment of infant color at delivery. Arch Dis Child Fetal Neonatal Ed. 2007;92:F465467.
Ainsworth S, Wyllie JP, Wren C. Prevalence and clinical significance of cardiac murmurs in neonates. Arch Dis Child Fetal Neonatal Ed. 1990;80:F43-45.
Shultz A, Localio R, Clark B, Ravishankar C, Videon N, Kimmel S. Epidemiologic features of the presentation of critical congenital heart disease: implication for screening. Pediatrics. 2008; 121(4):751-757.
Ng B and Hokanson J. Missed congenital heart disease in neonates. Congenit Heart Dis. 2010; 5:292-296.
Thangaratinam S, Brown K, Zamora J, Khan K, Ewer A. Pulse oximetry screening for critical congenital heart defects in asymptomatic newborn babies: a systematic review and meta-analysis. Lancet. 2012; 379: 2459-64.
Downloads
Published
Versions
- 2017-11-20 (2)
- 2018-11-27 (1)
Issue
Section
License
Copyright (c) 2018 Acta Médica Costarricense
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Los autores que publican en la revista Acta Médica Costarricense pueden distribuir, copiar, remezclar, retocar, leer, descargar, imprimir, buscar y crear a partir de su obra de modo no comercial, indicando los créditos a la revista y sus autores y compartir su obra en las mismas condiciones. Para ello se aplica la licencia Creative Commons Reconocimiento-NoComercial-CompartirIgual 4.0 Internacional(CC BY-NC-SA 4.0)
